C.M. Bidwell & Associates’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-390
Closed -$48K – 436
2018
Q4
$48K Sell
390
-360
-48% -$59.3K 0.05% 245
2018
Q3
$183K Sell
750
-430
-36% -$99.4K 0.17% 143
2018
Q2
$220K Sell
1,180
-660
-36% -$110K 0.2% 127
2018
Q1
$226K Sell
1,840
-570
-24% -$69.6K 0.21% 130
2017
Q4
$287K Sell
2,410
-415
-15% -$45.7K 0.25% 113
2017
Q3
$269K Sell
2,825
-740
-21% -$71.3K 0.41% 97
2017
Q2
$340K Buy
3,565
+875
+33% +$74.8K 0.07% 109
2017
Q1
$209K Buy
+2,690
New +$186K 0.05% 153

Other funds holding INGN

C.M. Bidwell & Associates's INGN Position: Q1 2019 in Review

C.M. Bidwell & Associates sold out of Inogen (INGN) in Q1 2019, closing a stake of 390 shares — an estimated $48K sold.

C.M. Bidwell & Associates first reported a position in INGN in Q1 2017 and held it in 8 quarters. The position peaked at $340K in Q2 2017. 239 funds tracked by Wall St. Rank hold INGN as of Q1 2019.

  • C.M. Bidwell & Associates reported no remaining Inogen position as of Q1 2019 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 390 Inogen shares in Q1 2019, an estimated $48K.
  • C.M. Bidwell & Associates first reported a position in Inogen in Q1 2017 and held it in 8 quarters.
  • C.M. Bidwell & Associates's Inogen position peaked at $340K in Q2 2017.
  • 239 funds tracked by Wall St. Rank held Inogen as of Q1 2019.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2019, filed 15 May 2019.